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BACKGROUND/OBJECTIVES: Whether fat-free mass (FFM) and its components are depleted in eating-disorder (ED) patients is
uncertain. Dual energy X-ray absorptiometry (DXA) is widely used to assess body composition in pediatric ED patients; however, its
accuracy in underweight populations remains unknown. We aimed (1) to assess body composition of young females with ED
involving substantial weight loss, relative to healthy controls using the four-component (4C) model, and (2) to explore the validity
of DXA body composition assessment in ED patients.
SUBJECTS/METHODS: Body composition of 13 females with ED and 117 controls, aged 10–18 years, was investigated using the 4C
model. Accuracy of DXA for estimation of FFM and fat mass (FM) was tested using the approach of Bland and Altman.
RESULTS: Adjusting for age, height and pubertal stage, ED patients had signiﬁcantly lower whole-body FM, FFM, protein mass (PM)
and mineral mass (MM) compared with controls. Trunk and limb FM and limb lean soft tissue were signiﬁcantly lower in ED patients.
However, no signiﬁcant difference in the hydration of FFM was detected. Compared with the 4C model, DXA overestimated FM by
5± 36% and underestimated FFM by 1± 9% in ED patients.
CONCLUSION: Our study conﬁrms that ED patients are depleted not only in FM but also in FFM, PM and MM. DXA has limitations
for estimating body composition in individual young female ED patients.
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INTRODUCTION
Eating disorders (ED) involving severe weight loss have a lifetime
prevalence in women of 2%–4% in Western industrialized
populations, with adolescents most at risk.1 Patients with anorexia
nervosa (AN) and some atypical ED are characterized by loss of fat
mass (FM), which has important physiological consequences.
However, the literature on fat-free mass (FFM) depletion and its
components is inconsistent, in particular the extent to which
muscle wasting occurs in these patients.
Some studies found lower FFM in AN patients compared with
controls,2–6 whereas others reported no difference.7–11 This
inconsistency also applies to other diseases of malnutrition. In
dialysis patients with chronic renal failure, some studies found
reduced FFM compared with controls,12,13 whereas another study
found no difference.14 Cystic ﬁbrosis patients had lower FFM than
controls in adolescence, but not in childhood.15,16
Some studies have further reported that FFM components,
including mineral2,17–19 and protein mass (PM),2,4,20,21 are
signiﬁcantly reduced in AN patients. PM declines in proportion
with disease severity;4,21 however, the protein component of FFM
may be rapidly replenished after weight regain.20 In other diseases
of malnutrition, PM was also found to be depleted; however, this
was not reﬂected by simple anthropometric measurements.22–24
Body mass index (BMI) is the most widely used measure of
nutritional status in ED patients and gains in BMI during treatment
are considered a sign of improved health. However, BMI is a
poor index of fatness in females with ED, explaining only ~ 50%
of the variance in percentage fat estimated by skinfolds or
densitometry.25 Change in BMI was also reported to be a poor
indicator of body composition change in such patients.26 Other
techniques such as dual-energy X-ray absorptiometry (DXA) are
increasingly used; however, accuracy of DXA in healthy children
and adolescents is imperfect27,28 and its validity in ED patients has
been evaluated only against skinfold thickness and BMI,29 which
are not suitable reference methods.
The primary aim of this study was to compare body
composition between adolescent girls with EDs and healthy
controls. We used the four-component (4C) model, the ‘gold
standard’ for assessing tissue masses, as it minimizes theoretical
assumptions concerning the properties of FFM and hence
measures FM more accurately. It also allows possible differences
in PM and mineral mass (MM) to be examined. The secondary aim
was to evaluate the utility of BMI and DXA for estimating body




Subjects included 13 female ED patients involving substantial weight loss
and 117 female controls, aged between 10 and 18 years. The patients were
recruited from a specialist clinic at Great Ormond Street Hospital, London,
a tertiary referral hospital. All had been diagnosed previously and were
referred either because of clinical deterioration or because, despite
medical stabilization, they were not responding to treatment. All patients
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met full criteria for AN at some point and would therefore be diagnosed
with AN using DSM5 criteria.
Controls were recruited from an ongoing body composition research
project for healthy children and adolescents. Controls were healthy, born
full-term (437 weeks gestation) and had never taken any medication
affecting their growth or nutritional status. They also had no history of EDs.
The study was approved by the Research Ethics Committee of UCL Institute
of Child Health/Great Ormond Street Hospital. All subjects over 16 years of
age gave written consent before participating in the study; parents or
guardians gave written consent for younger subjects, who also gave verbal
assent.
Anthropometry
Body weight was measured with minimum clothing to 0.01 kg using an
electronic scale integral to the air-displacement plethysmography instru-
mentation (see below). Height was measured to 1mm using a wall-
mounted stadiometer (Holtain, Dyfed, UK). BMI was calculated as weight/
height2. Circumferences of the mid-upper arm, waist, hips, thigh and calf
were also measured using a non-stretchable ﬂexible tape. Height, weight,
BMI and waist circumference were converted into s.d. scores using current
UK 1990 reference data.30,31 Pubertal status was self-assessed using line
drawings.
Deuterium oxide dilution
Total body water (TBW) was determined by deuterium oxide, using an oral
dose equivalent to 0.05 g of 99.9 atom% deuterium-labelled water per kg
body weight. Saliva samples were collected using cotton wool swabs at
baseline and 4 h after dosing. Isotopic enrichment of saliva samples was
determined by isotope-ratio mass spectrometry.32 Raw TBW was corrected
for any drinks consumed during the equilibration period.
Air-displacement plethysmography
Body volume was measured by air-displacement plethysmography using
BODPOD instrumentation (Life Measurement Instruments, Concord, CA,
USA). The subjects wore a close-ﬁtting swimming costume and swimming
cap. Two complete tests (that is, a minimum of four raw volume
measurements) were performed on each subject.32 Lung volume was
predicted using age- and sex-speciﬁc equations.33
Dual-energy X-ray absorptiometry
Bone mineral content was measured using DXA (Lunar Progidy, Madison,
WI, USA). The subjects removed objects and clothes containing metal
before undergoing the scan. Subjects lay supine, with arms and legs at
their sides. The typical scan duration was 10–15min, depending on height.
The estimated radiation exposure was 2.2 μSv per scan. Data on whole
body and regional FM, bone mineral content and non-bone lean soft tissue
were extracted.
Four-component model
The 4C model differentiates weight into FM, water, protein and mineral.
Using the raw measurements described above, FM can be calculated using
the following equation:34
FM (kg) = 2.747 (body volume)− 0.71 (TBW)+1.46 (bone mineral con-
tent)− 2.05 (weight)
FFM was calculated as: weight− FM
To aid initial comparison of patients and controls, FM and FFM were
adjusted for height, by calculating the FM index (FMI = FM/height2) and
FFM index (FFMI=FFM/height2). Hydration of FM (HFFM) was calculated as
TBW/FFM. Total body MM was calculated as bone mineral content×1.2741.34
PM was calculated as FFM− (MM+TBW). The protein:mineral ratio indicates
the degree of mineralization of fat-free tissue.
A Hattori plot35 was generated to express the relative contributions of
FFMI versus FMI to BMI in the ED patients and controls. Whole-body FM
and FFM by the 4C model, and regional fat and lean soft tissue by DXA,
were expressed as z-scores relative to the UK reference data.33
Sample size and statistical analysis
We aimed to recruit 16 ED patients, which would be adequate to identify a
1 s.d. difference in any outcome relative to 16 controls. However, to
increase statistical power of the comparison and to be able to address a
wide range of size and pubertal status in the controls, we analyzed all
available data from a study of healthy girls, which have been published as
the UK body composition reference data.33
All statistical analyses were performed using Statistical Package for the
Social Sciences (SPSS v.15 for Windows, SPSS Inc, Chicago, IL, USA).
Independent sample t-tests and χ2-tests were used to test for differences in
background characteristics, age and anthropometry between the patients
and controls.
General linear models were used to test for differences in body
circumferences, FM, FFM and the various components of FFM including
water, protein and mineral, and regional body composition (by DXA)
between patients and controls, adjusting for potential confounding factors
(age, height and pubertal stage). To express differences in percentage
terms, raw data were log-transformed and the regression coefﬁcients
multiplied by 100%.
Pearson’s correlations were used to investigate associations between
BMI and body composition estimated by the 4C model (FMI and FFMI) in
the patients and controls. Bland–Altman analyses were used to assess the
bias in body composition measurements of the ED patients by DXA, using
4C data as the reference method.36 Limits of agreement between
measurements were expressed as ± 2 s.d. of the mean bias. The correlation
between the bias and mean of measured values was also determined. The
bias was expressed as percent of the mean by natural log transformation
of the bias of individual values and multiplying by 100.
RESULTS
The control girls and ED patients were all White Europeans, except
for one ED patient who was Indian. This patient did not
signiﬁcantly differ in age or any of the anthropometric or body
composition measurements compared with the rest of the
patients; therefore, her data were included in the analyses. All
subjects had data for the 4C model, except for one ED patient who
only had a DXA scan. Therefore, the main comparisons of ED
versus controls, and of the accuracy of DXA, involved 12 ED
patients and 117 controls; however, an additional ED data point
was available for the regional DXA comparison.
Characteristics of the ED patients and controls are presented in
Table 1. The patients were aged between 10 and 18 years with a
mean of 15.3 ± 1.9 years. Control girls were also aged between 10
Table 1. Description of the sample: background characteristics, age
and anthropometry
Eating disorders Controls
N Mean s.d. N Mean s.d
Age (years)* 13 15.3 1.9 117 13.7 2.0
Birth weight (kg) 12 3.3 0.6 116 3.5 0.5
Maternal BMI (kgm− 2) 12 25.7 5.3 112 25.3 5.4
Paternal BMI (kgm− 2) 12 25.0 4.0 105 26.4 3.9
Raw measures
Weight (kg)** 13 43.4 5.9 117 51.8 12.4
Height (m) 13 1.58 0.10 117 1.60 0.10
BMI (kgm− 2)** 13 16.9 1.4 117 20.6 3.7
Weight SDS** 13 − 1.4 1.0 117 0.4 1.1
Height SDS 13 − 0.1 1.3 117 0.3 0.9
BMI SDS** 13 − 1.5 1.0 117 0.3 1.2
Circumferences (cm)
Mid-upper arm** 12 21.6 1.7 117 25.8 3.7
Hip* 12 82.1 5.8 117 88.6 11.0
Thigh** 12 44.7 3.4 116 50.7 6.9
Calf* 12 30.4 2.0 117 33.0 3.6
Waist** 12 62.9 2.7 117 69.1 8.0
Waist SDS** 11 − 0.2 0.5 105 1.0 1.0
Abbreviations: BMI, body mass index; SDS, s.d. scores. Groups compared by
two-sample t-test. *P= 0.05, **Po0.001.
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and 18 years, but were on average 1.6 years younger than those
with EDs (P= 0.006) and had earlier pubertal stage (3.2, s.d 1.3 vs
3.6, s.d 1.4), signiﬁcant by χ2-test (P= 0.007). As expected, the ED
group had signiﬁcantly lower weight and BMI s.d. scores
(Po0.001) than the controls. The controls were 2.9 cm taller,
equivalent to 0.4 s.d. scores, but not signiﬁcantly so (P= 0.2). The
mean BMI s.d. scores of 0.34 (s.d. 1.19) in the controls indicate that
they are representative of British girls in general.33
In terms of background characteristics, there were no signiﬁcant
differences for birth weight and parental BMI between patients
and controls. However, all anthropometric measurements differed
signiﬁcantly between the groups, including body circumferences.
Table 2 presents the body composition outcomes. The only
statistically signiﬁcant differences were lower body volume, FM,
FFMI and FMI in the ED patients. The s.d. scores for FM and FFM
were also signiﬁcantly lower in the patients. Figure 1 shows a
Hattori plot of FMI versus FFMI in ED patients and controls. The ED
patients were all low on the graph, conﬁrming their uniformly low
FMI compared with the controls. They were also grouped towards
the left-hand side of the graph, indicating a lower range of FFMI.
However, due to the difference between groups in mean age,
further statistical adjustments were required to test for differences
in regional body composition and FFM composition. The
hydration value of 72.8% gave no indication of edema in the
ED group.
After adjusting for height and age, the ED patients had mean
deﬁcits of 20.4% in mid-upper arm girth, 11.1% in waist girth,
11.7% in hip girth, 14.9% in thigh girth and 11.0% in calf girth.
These data indicate a greater depletion of upper arm and upper
leg tissue compared with abdominal regions.
Table 3 illustrates crude whole-body composition differences
between ED patients, after adjusting for differences in age and
ﬁnally after adjusting for differences in age, pubertal status and
height. In all models, ED patients had signiﬁcantly lower FM, FFM,
MM and PM. After adjusting for age, height and puberty, the
deﬁcits compared with controls were equivalent to 51.9% in FM
(Po0.0001), 10.8% in FFM (Po0.0001), 12.2% in MM (Po0.001)
and 9.1% in PM (Po0.03). However, differences in hydration or
density of FFM did not reach signiﬁcance and no difference in the
protein:mineral ratio was found.
Regional body composition, assessed by DXA, was also
compared between ED patients and controls (Table 3). After
adjusting for age, sex and pubertal stage, the percentage deﬁcit in
FM was 76.1%, 58.9% and 58.6% for the arm, leg and trunk,
respectively. Equivalent deﬁcits for the bone were 11.4%, 10.9%
and 18.3%, and for lean soft tissue were 13.9%, 9.3% and 4.3%. As
with body girths, these data indicate greater loss of fat in the arm
compared with the trunk, and greater loss of lean tissue in the
limbs compared with the trunk. Using the new UK reference data,
mean s.d. scores of the patients were − 1.41 (0.84) for arm fat,
− 1.57 (0.79) for arm lean, − 1.60 (0.77) for leg fat, − 1.35 (0.93) for
leg lean, − 1.14 (0.69) for trunk fat and − 0.97 (0.93) for trunk lean,
all Po0.02 (see Supplementary Table S1 for full details).
The utility of BMI and DXA for body composition assessment
was then assessed using the 4C model as the reference method. In
ED patients, the correlation between BMI and FMI estimated by
the 4C model was low and not statistically signiﬁcant (r= 0.47;
P= 0.1), whereas in controls this correlation was highly signiﬁcant
(r= 0.92; Po0.001). The correlation between BMI and FFMI in both
groups was highly signiﬁcant (ED patients: r= 0.85; Po0.001;
controls: r= 0.76; Po0.001).
The evaluation of the accuracy of DXA for body composition
assessment is given in Table 4. In the ED patients, DXA was found
to overestimate FM and underestimate FFM by 4.6% and 0.9%,
respectively. Even though the bias was not very high, the limits of
agreement for FM and FFM were ± 36.4% and ± 9.4%, respectively.
Similarly, compared with the 4C model, DXA was found to
overestimate FM and underestimate FFM in the control girls. The
magnitude of the biases in FM and FFM did not differ signiﬁcantly
between ED patients and controls. A graphical illustration of the
ﬁndings for the ED patients is shown in Figure 2.
DISCUSSION
Our study demonstrates that female adolescents with EDs
involving substantial weight loss have reduced FM and FFM
compared with controls, after adjusting for differences in age,
height and pubertal stage. In addition, there were signiﬁcant
deﬁcits in the protein and mineral components of FFM, although
Table 2. Body composition outcomes for the ED patients and controls
EDs Controls
N Mean s.d N Mean s.d
Raw measurements
Body volume (l)a 12 41.1 5.8 117 50.2 12.5
Total body water (l) 12 25.9 4.2 117 27.6 5.2
4C model outcomes
FFM (kg) 12 35.4 5.6 117 36.9 7.1
FM (kg)a 12 7.9 1.9 117 14.8 7.1
FFM-SDSa 12 − 1.13 1.02 117 0.02 1.02
FM-SDSa 12 − 1.41 0.97 117 0.11 1.06
FFMI (kgm− 2)b 12 13.8 1.3 117 14.7 1.6
FMI (kgm− 2)b 12 3.1 0.8 117 5.9 2.6
HFFM (%) 12 72.8 0.9 117 74.6 1.6
DFFM (kg/l) 12 1.097 0.004 117 1.096 0.006
Mineral mass (kg) 12 2.4 0.5 117 2.5 0.6
Protein mass (kg) 12 6.8 1.1 117 6.9 1.5
Protein:mineral ratio 12 2.9 0.4 117 2.9 0.4
Abbreviations: 4C, 4-component model; DFFM, density of FFM; ED, eating
disorder; FM, fat mass; FFM, fat-free mass; FMI, fat mass index; FFMI, fat-free
mass index; HFFM, hydration of FFM; SDS, s.d score.
aSigniﬁcant difference
between groups at P o0.001. bSigniﬁcant difference between group at
Po0.05.
Figure 1. A Hattori plot illustrating differences in FMI and FFMI by
the 4C model between ED patients and controls. As FMI and FFMI
add up to BMI, downward-crossing diagonal lines express constant
BMI values. The ED patients have reduced FMI and FFMI relative to
the control population.
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not of sufﬁcient magnitude to indicate differences in the physical
or biological properties of fat-free tissue. In addition to differences
in whole-body composition, weight loss differed by region. ED
patients had bone and FM deﬁcits in their trunks and limbs, and
lower lean soft tissue in their limbs. Although consistent with
anthropometric data on girths, the magnitudes of these regional
DXA soft tissue differences are less reliable than the equivalent
whole-body 4C data, as we further demonstrated poor accuracy of
DXA for estimating body composition, especially fatness, in ED
patients.
Previous studies describing body composition differences
between AN patients and controls have been inconsistent.2–9,11
This inconsistency may be due in part to the use of different body
composition methods. DXA has been used in several studies of ED
patients;2,5,37 however, these studies have not demonstrated the
validity of DXA in ED patients using an accurate reference method.
In healthy children and adolescents, the accuracy of DXA has been
shown to vary across the range of nutritional status.27,28
In the present study, the limits of agreement for DXA are similar
in absolute terms in ED patients (±3 kg FM or FFM) to those in
healthy subjects (±2.6 kg). In percentage terms, owing to the
smaller tissue masses, these differences are relatively greater in ED
patients (±36% FM and ± 9% FFM). These ﬁndings support our
earlier conclusion that DXA may have limitations for monitoring
change in body composition in individuals gaining or losing tissue
masses.27
PM is expected to correlate with height and, independently, to
increase during pubertal maturation. An important component of
our work was therefore to disentangle the greater age and more
advanced pubertal stage of our patients relative to the controls,
from their shorter height. After these adjustments, PM was
signiﬁcantly lower in the ED patients. This agrees with the ﬁndings
from several previous studies of adolescents with EDs, which
estimated total body nitrogen by in-vivo neutron activation
analysis.2,20,29 In-vivo neutron activation analysis is used as an
index of PM on the assumption that 98% of nitrogen is contained
in protein.38 Accuracy of in-vivo neutron activation analysis for PM
is estimated at 3%–7%;39 however, a disadvantage of using in-vivo
neutron activation analysis is that unlike the 4C model, it provides
no data on other components of FFM. Protein depletion in
children with chronic renal failure contributed to growth failure
and severe stunting,40 which have also been described in patients
with AN.41,42 Therefore, the ability to monitor PM would be
valuable in the clinical management of ED patients.
We also observed depleted MM in the ED patients, consistent
with some previous studies,43,44 although another study showed
no signiﬁcant deﬁcit.45 Inconsistent ﬁndings between studies may
be due to variability in the duration of illness, as the study with
negative ﬁndings assessed bone mineral status in adolescents
soon after the onset of AN, whereas we studied a heterogeneous
sample of ED patients referred to a tertiary treatment centre, many
Table 3. Differences in whole-body and regional composition between 12 ED patients versus 117 controls, by general linear model
Adjusted age Adjusted age, height, puberty
Mean s.e. P-values Mean s.e. P-values
Whole-body composition
FM (kg) − 8.3 2.0 o0.001 − 7.7 2.0 o0.001
FFM (kg) − 5.9 1.6 o0.001 − 4.0 1.1 o0.001
Mineral mass (kg) − 0.5 0.1 o0.001 − 0.3 0.1 0.001
Protein mass (kg) − 0.9 0.3 0.005 − 0.6 0.3 0.028
HFFM (%) − 0.5 0.5 0.3 − 0.4 0.5 0.4
DFFM (kg/l) 0.000 0.002 0.8 0.001 0.001 0.6
Protein:mineral ratio 0.2 0.1 0.2 0.1 0.1 0.4
Regional composition
Trunk fat (kg) − 4.4 1.2 o0.001 − 4.0 1.0 o0.001
Trunk non-bone lean (kg) − 1.6 0.7 0.015 − 0.8 0.5 0.089
Trunk bone (g) − 174 40 o0.001 − 124 30 o0.001
Arm fat (kg) − 1.0 0.2 o0.001 − 0.9 0.2 o0.001
Arm non-bone lean (kg) − 0.3 0.2 0.11 − 0.5 0.2 0.002
Arm bone (g) − 7 19 0.7 − 31 10 0.003
Leg fat (kg) − 3.0 0.8 o0.001 − 3.5 0.8 o0.001
Leg non-bone lean (kg) − 0.6 0.6 0.32 − 1.1 0.4 0.003
Leg bone (g) − 40 53 0.4 − 85 28 0.003
Abbreviations: DFFM, density of FFM; ED, eating disorder; FMI, fat mass index; FFMI, fat-free mass index; HFFM, hydration of FFM. Differences calculated as:
ED− control.
Table 4. Evaluation of the accuracy of DXA for body composition
assessment in ED patients and controls, using the 4C model as the
reference method
Bias Correlation
Mean Limits of agreement P-values r P-values
(kg) (%) (kg) (%)
ED patients
FM 0.4 4.6 ± 3.1 ± 36.4 0.4 − 0.40 0.2
FFM − 0.3 − 0.9 ± 3.2 ± 9.4 0.5 0.19 0.5
FMI 0.2 4.6 ± 1.2 ± 36.4 0.4 − 0.36 0.2
FFMI − 0.1 − 0.9 ± 1.2 ± 9.4 0.5 0.25 0.4
Controls
FM 1.1 7.4 ± 2.6 ± 23.2 o0.001 0.37 o0.001
FFM − 1.2 − 3.2 ± 2.5 ± 6.2 o0.001 − 0.48 o0.001
FMI 0.4 7.4 ± 1.0 ± 23.2 o0.001 0.23 0.011
FFMI − 0.5 − 3.2 ± 0.9 ± 6.2 o0.001 − 0.41 o0.001
Abbreviations: 4C, 4-component model; DXA, dual X-ray absorptiometry;
FM, fat mass; FMI, FM index; FFM, fat-free mass; FFMI, FFM index. Bias
calculated as DXA value− 4C value. Limits of agreement calculated as twice
the s.d. of the bias. Correlation between magnitude of bias and the mean
value by both techniques.
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of whom have had chronic or established illness despite their
young age. More generally, the duration of malnutrition is
considered an important predictor of bone loss.46
Most work on the nutritional status of ED patients has relied on
weight and height indices. In our patients, only 22% of the
variance in FMI could be predicted by BMI. This is consistent with
ﬁndings from previous studies from healthy subjects47 and AN
patients,25 showing that BMI does not accurately reﬂect body
composition, especially fatness, and may be especially poor for
monitoring disease progression and response to treatment.
The main limitation of our study is the small sample size for the
ED patients and we did not manage to recruit our target of 16
patients. However, owing to the powerful effect of EDs on body
composition and the large number of control subjects, we were
able to detect statistically signiﬁcant differences in almost all
outcomes compared with healthy controls. Equally, our evaluation
of DXA is complemented by previous work demonstrating
differential bias across the entire range of nutritional status.
Hence, despite the small sample size, our main conclusions are
likely to be robust. Another limitation is the use of self-reported
puberty status48 rather than physical examination. However,
adjustment for puberty made little difference to the results,
whereas size was more important.
In summary, our study using the gold standard 4C model
demonstrates reduction in FM, FFM, PM and MM in adolescent ED
patients, relative to healthy controls. Previously, FFM and PM have
been shown to predict clinical outcome and morbidity during
starvation and other illnesses of malnutrition. Hence, accurate
measurements of body composition in ED patients may be
important for monitoring the success of their treatment and in
preventing future complications such as bone loss and infertility. A
multi-component model may be more accurate for such long-
itudinal measurements than DXA.
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